FDA Warns Public About Inaccuracy Issues With Abbott's Coronavirus Test
The U.S. Food and Drug Administration alerted the public on Thursday evening that Abbott's (NYSE: ABT) ID NOW coronavirus test could have some serious issues. After receiving 15 adverse event reports the FDA issued a warning that the test could be delivering negative results to people who actually are COVID-19 positive.
The FDA says Abbott's rapid point-of-care test can still be used to correctly identify many positive cases in minutes. Negative results from patients that display any symptoms, though, need to be confirmed with older molecular diagnostics that slowly amplify genetic material with an old-fashioned incubation process.
Image source: Getty Images.
Source Fool.com
